396 related articles for article (PubMed ID: 28253990)
1. Mitochondrial Perturbation in Alzheimer's Disease and Diabetes.
Akhter F; Chen D; Yan SF; Yan SS
Prog Mol Biol Transl Sci; 2017; 146():341-361. PubMed ID: 28253990
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.
Cai Q; Tammineni P
J Alzheimers Dis; 2017; 57(4):1087-1103. PubMed ID: 27767992
[TBL] [Abstract][Full Text] [Related]
3. OCIAD1 contributes to neurodegeneration in Alzheimer's disease by inducing mitochondria dysfunction, neuronal vulnerability and synaptic damages.
Li X; Wang L; Cykowski M; He T; Liu T; Chakranarayan J; Rivera A; Zhao H; Powell S; Xia W; Wong STC
EBioMedicine; 2020 Jan; 51():102569. PubMed ID: 31931285
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline.
Reddy PH; Manczak M; Mao P; Calkins MJ; Reddy AP; Shirendeb U
J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S499-512. PubMed ID: 20413847
[TBL] [Abstract][Full Text] [Related]
5. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.
Wang X; Su B; Zheng L; Perry G; Smith MA; Zhu X
J Neurochem; 2009 May; 109 Suppl 1(Suppl 1):153-9. PubMed ID: 19393022
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.
Guo L; Tian J; Du H
J Alzheimers Dis; 2017; 57(4):1071-1086. PubMed ID: 27662318
[TBL] [Abstract][Full Text] [Related]
7. March separate, strike together--role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer's disease.
Eckert A; Nisbet R; Grimm A; Götz J
Biochim Biophys Acta; 2014 Aug; 1842(8):1258-66. PubMed ID: 24051203
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks.
Correia SC; Perry G; Moreira PI
Biochim Biophys Acta; 2016 Oct; 1862(10):1909-17. PubMed ID: 27460705
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease.
Verri M; Pastoris O; Dossena M; Aquilani R; Guerriero F; Cuzzoni G; Venturini L; Ricevuti G; Bongiorno AI
Int J Immunopathol Pharmacol; 2012; 25(2):345-53. PubMed ID: 22697066
[TBL] [Abstract][Full Text] [Related]
10. Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease.
Magi S; Castaldo P; Macrì ML; Maiolino M; Matteucci A; Bastioli G; Gratteri S; Amoroso S; Lariccia V
Biomed Res Int; 2016; 2016():6701324. PubMed ID: 27340665
[TBL] [Abstract][Full Text] [Related]
11. A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam.
Stockburger C; Miano D; Baeumlisberger M; Pallas T; Arrey TN; Karas M; Friedland K; Müller WE
J Alzheimers Dis; 2016; 50(1):201-15. PubMed ID: 26639968
[TBL] [Abstract][Full Text] [Related]
12. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M; Rockenstein E; Crews L; Masliah E
Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease.
Cabezas-Opazo FA; Vergara-Pulgar K; Pérez MJ; Jara C; Osorio-Fuentealba C; Quintanilla RA
Oxid Med Cell Longev; 2015; 2015():509654. PubMed ID: 26221414
[TBL] [Abstract][Full Text] [Related]
14. The impairment of insulin signaling in Alzheimer's disease.
Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI
IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer's Disease.
Adiele RC; Adiele CA
J Alzheimers Dis; 2016 Jul; 53(4):1257-70. PubMed ID: 27392851
[TBL] [Abstract][Full Text] [Related]
16. Key role of mitochondria in Alzheimer's disease synaptic dysfunction.
Cavallucci V; Ferraina C; D'Amelio M
Curr Pharm Des; 2013; 19(36):6440-50. PubMed ID: 23432718
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction and Alzheimer's disease.
Maruszak A; Żekanowski C
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):320-30. PubMed ID: 20624441
[TBL] [Abstract][Full Text] [Related]
18. Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.
Amadoro G; Corsetti V; Atlante A; Florenzano F; Capsoni S; Bussani R; Mercanti D; Calissano P
Neurobiol Aging; 2012 Apr; 33(4):833.e1-25. PubMed ID: 21958963
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between β-Amyloid and Mitochondrial Dynamics.
Kim DI; Lee KH; Oh JY; Kim JS; Han HJ
Cell Mol Neurobiol; 2017 Aug; 37(6):955-968. PubMed ID: 27766447
[TBL] [Abstract][Full Text] [Related]
20. Early selective vulnerability of synapses and synaptic mitochondria in the hippocampal CA1 region of the Tg2576 mouse model of Alzheimer's disease.
Balietti M; Giorgetti B; Casoli T; Solazzi M; Tamagnini F; Burattini C; Aicardi G; Fattoretti P
J Alzheimers Dis; 2013; 34(4):887-96. PubMed ID: 23313923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
